OBJECTIVE:HELLP syndrome is a severe preeclampsia spectrum
disorder diagnosed when laboratory evidence of hemolysis, liver dysfunction and
thrombocytopenia are present. The presence of epigastric pain with laboratory
criteria for HELLP syndrome may indicate higher maternal-fetal risk. Thus we
explored maternal outcomes in 42 pregnant/postpartum women that had HELLP syndrome
by laboratory criteria in addition to sudden severe epigastric pain. METHODS: A database was constructed from the medical files of all patients with
medical/hypertensive disorders evaluated by the first author from 1986-2015 for
medicolegal purposes. All patient files of women who presented to their
physicians with a diagnosis of presumptive HELLP syndrome were examined. RESULTS: Fifty-eight pregnant/postpartum women fulfilled study
inclusion criteria; they presented to physicians for evaluation usually in
non-tertiary care hospital settings. Clinical presentation and care including
lab data and details of pregnancy outcome were evaluated. A correct diagnosis
of HELLP syndrome was verified for 42 women (72.4%); others were determined to
have AFLP-Acute Fatty Liver of Pregnancy (n=8) or TTP-aHUS-Thrombotic thrombocytopenic
purpura-adult/atypical hemolytic uremic syndrome (n
References
[1]
Weinstein, L. (1982) Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count: A Severe Consequence of Hypertension in Pregnancy. American Journal of Obstetrics and Gynecology, 142, 159-167.
https://doi.org/10.1016/S0002-9378(16)32330-4
[2]
Wallace, K., Harris, S., Addison, A. and Bean, C. (2018) HELLP Syndrome: Pathophysiology and Current Therapies. Current Pharmaceutical Biotechnology, 19, 816-826. https://doi.org/10.2174/1389201019666180712115215
[3]
Ankumah, N.E. and Sibai, B.M. (2015) HELLP Syndrome: Clinical & Laboratory Diagnosis. In: Martin Jr., J.N., Ed., The 2015 Compendium for HELLP Syndrome: From Bench to Bedside, Nova Science Publishers, Inc., New York, 19-28.
[4]
Martin, J.N.Jr., Rinehart, B.K., May, W.L., Magann, E.F., Terrone, D.A. and Blake, P.G. (1999) The Spectrum of Severe Preeclampsia: Comparative Analysis by HELLP (Hemolysis, Elevated Liver Enzyme Levels, and Low Platelet Count) Syndrome Classification. American Journal of Obstetrics and Gynecology, 180, 1373-1384.
https://doi.org/10.1016/S0002-9378(99)70022-0
[5]
Martin Jr., J.N. (2013) The Howard Taylor Lecture: Milestones in the Quest for Best Management of Patients with HELLP Syndrome (Microangiopathic Hemolytic Anemia, Hepatic Dysfunction, Thrombocytopenia). International Journal of Gynecology & Obstetrics, 121, 202-207. https://doi.org/10.1016/j.ijgo.2013.02.001
[6]
Martin Jr., J.N., Brewer, J.M., Wallace, K., Sunesara, I., Canizaro, A., Blake, P.G., Lamarca, B. and Owens, M.Y. (2013) HELLP Syndrome and Composite Major Maternal Morbidity: Importance of Mississippi Classification System. The Journal of Maternal-Fetal & Neonatal Medicine, 26, 1201-1206.
https://doi.org/10.3109/14767058.2013.773308
[7]
O’Brien, J.M. and Barton, J.R. (2005) Controversies with the Diagnosis and Management of HELLP Syndrome. Clinical Obstetrics and Gynecology, 48, 460-477.
https://doi.org/10.1097/01.grf.0000160309.73197.35
[8]
Vidaeff, A.C. and Yeomans, E.R. (2007) Corticosteroids for the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP): What Evidence? Minerva Obstetrics and Gynecology, 59, 183-190.
[9]
Barton, J.R. (2015) HELLP Syndrome: Controversy over Corticosteroids. In: Martin Jr., J.N., Ed., The 2015 Compendium for HELLP Syndrome: From Bench to Bedside, Nova Science Publishers, Inc., New York, 63-75.
[10]
Roberts, J.M., et al. (2013) Hypertension in Pregnancy: Report of the ACOG Task Force on Hypertension in Pregnancy. Obstetrics & Gynecology, 122, 1122-1131.
https://doi.org/10.1097/01.AOG.0000437382.03963.88
[11]
Yang, L., Ren, C., Mao, M. and Cui, S. (2016) Prognostic Factors of the Efficacy of High-Dose Corticosteroid Therapy in Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome during Pregnancy: A Meta-Analysis. Medicine, 95, e3203.
https://doi.org/10.1097/MD.0000000000003203
[12]
Mao, M. and Chen, C. (2015) Corticosteroid Therapy for Management of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis. Medical Science Monitor, 21, 3777-3783.
https://doi.org/10.12659/MSM.895220
[13]
Martin, J.N.Jr. and Tucker, J.M. (2020) Missing or Making the Timely Diagnosis of Acute Fatty Liver of Pregnancy (AFLP): Lessons Learned. The Journal of Maternal-Fetal & Neonatal Medicine, 9, 1-7.
https://doi.org/10.1080/14767058.2020.1832075
[14]
Martin Jr., J.N. and Tucker, J.M. (2021) Maternal Morbidity and Mortality in Pregnant-Postpartum Women with Suspected HELLP Syndrome Identifiable as Probable TTP-aHUS by High LDH to AST Ratio. International Journal of Gynecology & Obstetrics, 11.
[15]
Martin, J.N.Jr. (2015) Core Concepts and Components of Best Management for Patients with HELLP Syndrome. In: Martin, J.N.Jr., Ed., the 2015 Compendium for HELLP Syndrome, Chapter 5, Nova Science Publishers, Inc., New York.
[16]
Martin Jr., J.N., Bailey, A.P., Rehberg, J.F., Owens, M.T., Keiser, S.D. and May, W.L. (2008) Thrombotic Thrombocytopenic Purpura in 166 Pregnancies: 1955-2006. American Journal of Obstetrics and Gynecology, 199, 98-104.
https://doi.org/10.1016/j.ajog.2008.03.011
[17]
Keiser, S.D., Boyd, K.W., Rehberg, J.F., Elkins, S., Owens, M.Y., Sunesara, I. and Martin Jr., J.N. (2012) A High LDH to AST Ratio Helps to Differentiate Pregnancy-Associated Thrombotic Thrombocytopenic Purpura (TTP) from HELLP Syndrome. The Journal of Maternal-Fetal & Neonatal Medicine, 25, 1059-1063.
https://doi.org/10.3109/14767058.2011.619603
[18]
ACOG Committee Opinion No. 767 (2019) Emergent Therapy for Acute-Onset, Severe Hypertension during Pregnancy and the Postpartum Period. Obstetrics & Gynecology, 133, 409-412.
[19]
Darby, M., Martin Jr., J.N., Mitchell, S.Q., Owens, M.Y. and Wallace, K. (2013) Using Case Reports to Determine When Liver Bleeding Occurs during Disease Progression in HELLP Syndrome. International Journal of Gynecology & Obstetrics, 123, 7-9. https://doi.org/10.1016/j.ijgo.2013.06.007
[20]
Perrone, L., Dohan, A., Bazeries, P., Guerrache, Y., Fohlen, A., Rousset, P., Aube, C., Laurent, V., Morel, O., Boudiaf, M., Hoeffel, C. and Soyer, P. (2015) Hepatic Involvement in HELLP Syndrome: An Update with Emphasis on Imaging Features. Abdominal Imaging, 40, 2839-2849. https://doi.org/10.1007/s00261-015-0481-1
[21]
Martin Jr., J.N.., Thigpen, B.D., Moore, R.C., Rose, C.H., Cushman, J. and May, W. (2005) Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood Pressure. Obstetrics & Gynecology, 105, 246-254.
https://doi.org/10.1097/01.AOG.0000151116.84113.56
[22]
Judy, A.E., McCain, C.L., Lawton, E.S., Morton, C.H., Main, E.K. and Druzin, M.L. (2019) Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California. Obstetrics & Gynecology, 133, 1151-1159.
https://doi.org/10.1097/AOG.0000000000003290
[23]
Martin Jr., J.N., Thigpen, B.D., Rose, C.H., Cushman, J., Moore, A. and May, W.L. (2003) Maternal Benefit of High-Dose Intravenous Corticosteroid Therapy for HELLP Syndrome. American Journal of Obstetrics and Gynecology, 189, 830-834.
https://doi.org/10.1067/S0002-9378(03)00763-4
[24]
Martin Jr., J.N., Owens, M.Y., Keiser, S.D., Parrish, M.F., Tam, K.B., Brewer, J.M., Cushman, J.L. and May, W.L. (2012) Standardized Mississippi Protocol Treatment of 190 Patients with HELLP Syndrome: Slowing Disease Progression and Preventing New Major Maternal Morbidity. Hypertension in Pregnancy, 31, 79-90.
https://doi.org/10.3109/10641955.2010.525277
[25]
Shields, L.E., Wiesner, S., Klein, C., Pelletreau, B. and Hedriana, H.L. (2017) Early Standardized Treatment of Critical Blood Pressure Elevations Is Associated with a Reduction in Eclampsia and Severe Maternal Morbidity. American Journal of Obstetrics & Gynecology, 216, 415.E1-415.E5.
https://doi.org/10.1016/j.ajog.2017.01.008
[26]
Wallace, K., Martin Jr., J.N., Tam, K., Wallukat, G., Dechend, R., Lamarca, B. and Owens, M.Y. (2013) Seeking the Mechanism(s) of Action for Corticosteroids in HELLP Syndrome: SMASH Study. American Journal of Obstetrics & Gynecology, 208, 380.E1-380.E8. https://doi.org/10.1016/j.ajog.2013.01.049
